TMEM62 and neoplasm: To test if TMEM62 overexpression could increase survival, we employed the same experimental design as shown above (OVCAR8-TMEM62-TetON), and we observed a significant increase in survival of G2 group (animals started on special diet 14 days after tumor cell injection), when compared with control and G1 (Figure 3G); no significant difference was observed between control and G1.